Search hospitals > Ohio > Columbus
Ohio State University
Claim this profileColumbus, Ohio 43210
Global Leader in Heart Failure
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for High Blood Pressure
Conducts research for Cancer
1255 reported clinical trials
216 medical researchers
Summary
Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Heart Failure, Leukemia, Lymphoma, High Blood Pressure, Cancer and other specialties. Ohio State University is involved with conducting 1,255 clinical trials across 1,714 conditions. There are 216 research doctors associated with this hospital, such as Floor Backes, MD, Uma Borate, MD, Michael V Knopp, MD, PhD, and Alice Mims.Area of expertise
1Heart Failure
Global LeaderStage III
BAROSTIM
Stage II
2Leukemia
Global LeaderCD19 positive
MLLr positive
FLT3 positive
Top PIs
Floor Backes, MDOhio State University Comprehensive Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Ovarian Cancer
22 reported clinical trials
60 drugs studied
Uma Borate, MDOhio State University Comprehensive Cancer Center3 years of reported clinical research
Studies Acute Myeloid Leukemia
Studies Leukemia
16 reported clinical trials
30 drugs studied
Michael V Knopp, MD, PhDThe Ohio State University Wexner Medical Center2 years of reported clinical research
Studies Anterior Cruciate Ligament Injury
Studies Digital PET/CT Imaging
15 reported clinical trials
35 drugs studied
Alice MimsOhio State University Comprehensive Cancer Center3 years of reported clinical research
Expert in Acute Myeloid Leukemia
Expert in Leukemia
16 reported clinical trials
32 drugs studied
Clinical Trials running at Ohio State University
Leukemia
Pulmonary Arterial Hypertension
Acute Myeloid Leukemia
Surgical Site Infection
Dementia
Non-Small Cell Lung Cancer
Syndrome
Goodpasture Syndrome
Parkinson's Disease
Acute Leukemia
Ruxolitinib + Stem Cell Transplant
for Acute Myeloid Leukemia
This research study is studying a drug that may help decrease the chances of relapse after Allogeneic Stem Cell transplantation for Acute Myeloid Leukemia. The name of the study drug involved in this study is: • Ruxolitinib
Recruiting3 awards Phase 2
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
SNDX-5613
for Acute Leukemia
Phase 1 dose escalation will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of revumenib in participants with acute leukemia. In Phase 2, participants will be enrolled in 3 indication-specific expansion cohorts to determine the efficacy, short- and long-term safety, and tolerability of revumenib.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ohio State University?
Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Heart Failure, Leukemia, Lymphoma, High Blood Pressure, Cancer and other specialties. Ohio State University is involved with conducting 1,255 clinical trials across 1,714 conditions. There are 216 research doctors associated with this hospital, such as Floor Backes, MD, Uma Borate, MD, Michael V Knopp, MD, PhD, and Alice Mims.
Where is Ohio State University located?
To reach Ohio State University Hospital in Columbus, OH, navigate to Medical Center Drive, continue past the intersection of Medical Center and 9th Avenue straight to University Hospital (Rhodes Hall) or Ross Heart Hospital. Use the Patient Valet on your right for parking. For convenience, consider using real-time driving directions from Waze to account for live traffic updates and road conditions.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Ohio State University Wexner Medical Center:
- Contact the financial counseling team at 614-293-0860, option 2.
- For the Medication Assistance Program, call 614-293-3868.
- For insurance inquiries, billing, and financial assistance questions, call 1-800-678-8037 or 614-293-2100.
- General inquiries: OSUCareConnection@osumc.edu
- Website-related issues: webmaster@osumc.edu
What insurance does Ohio State University accept?
The Ohio State University Wexner Medical Center accepts a wide range of insurance plans. This includes commercial plans like Aetna and Anthem; government programs such as the Breast and Cervical Cancer Project (BCCP), Medicaid (AmeriHealth Caritas), and Medicare; marketplace plans like Buckeye Ambetter, CareSource Marketplace, and Molina Healthcare of Ohio; and Medicaid plans including AmeriHealth Caritas, Buckeye Community Health Plan, CareSource, Humana Healthy Horizons, Medicaid Ohio Traditional, Molina Healthcare of Ohio, and UnitedHealthcare Community Plan. They also accept traditional Medicare plans and Medicare Plans with Medigap coverage, along with other government plans like TriCare.
What awards or recognition has Ohio State University received?
Ohio State University Hospital, located in Columbus, Ohio, is ranked #28 by U.S. News & World Report as a top research institution and #40 in NIH research funding, with over $367M in total funding. The hospital is actively involved in more than 2,000 research studies and clinical trials, highlighting its strong commitment to research excellence and support for researchers.